Vital Farms Q1 Loss Deepens Concerns on Margin and ERP Disruption

What happened

Vital Farms reported a Q1 loss of $0.03 per share, sharply missing the Zacks Consensus Estimate of $0.09 and down from $0.37 a year ago, though revenue topped expectations. The loss underscores that the revenue-process material weakness and ERP transition are eroding margins more than management signaled, contradicting the narrative that the disruption was merely a temporary order-pattern issue. This result introduces immediate risk to the 2026 net revenue outlook of $930M–$950M and the implied EBITDA margin, as fixed costs from new capacity build-out compound the operational friction. While the company maintains a net cash position, the governance overhang—with an unremediated material weakness—amplifies the cost of capital risk if the weakness persists. The stock's current price near $25.80 already discounts some execution noise, but the Q1 miss suggests that fair value could tilt toward the bear case of $21 without swift remediation.

Implication

The Q1 loss validates the bear-case scenario in the DeepValue report, where EBITDA margin compresses below 11% and revenue falls short. Investors should wait for the FY2025 10-K (expected by late February 2026) to assess if the material weakness is remediated. If remediation is confirmed and Q2 2026 shows normalized margins, the stock could recover toward the base case of $28. However, if the weakness persists or guidance is cut, the stock could test $20. Patience is warranted given the binary nature of the upcoming catalysts.

Thesis delta

The Q1 loss significantly undermines the base-case assumption that the ERP disruption was transitory and margins would hold near 12-14%. This creates a credible path to the bear case ($21) if the material weakness remains unremediated and revenue guidance for 2026 is reduced. The thesis now hinges on rapidly improving operational execution and control remediation, with a higher probability of downside risk until concrete proof emerges.